悪性中皮腫：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Malignant Mesothelioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Malignant Mesothelioma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Malignant Mesothelioma Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Malignant Mesothelioma 33
Nov 08, 2012: GSK’s Mesothelioma Drug Slows Disease Progression In Patients With Inactive NF2 Gene, Study Finds 33
Oct 02, 2012: Aduro Biotech Announces Enrollment Of First Patient In Mesothelioma Phase Ib Trial 33
Aug 29, 2012: Study Pinpoints Malignant Mesothelioma Patients Likely To Benefit From Drug Pemetrexed 34
Feb 07, 2012: Aduro Announces Publication Of Phase I Trial Data Of CRS-207 In Clinical Cancer Research 34
Dec 15, 2011: New Immuno-Gene Therapy Shows Promise For Treatment Of Malignant Mesothelioma, Penn Researchers Report 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Verastem, Inc. 39
Clinical Trial Overview of Verastem, Inc. 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Polaris Group 42
Clinical Trial Overview of Polaris Group 42
MolMed S.p.A. 43
Clinical Trial Overview of MolMed S.p.A. 43
Eisai Inc. 44
Clinical Trial Overview of Eisai Inc. 44
Aduro BioTech, Inc. 45
Clinical Trial Overview of Aduro BioTech, Inc. 45
Anza Therapeutics, Inc. 46
Clinical Trial Overview of Anza Therapeutics, Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
National Cancer Institute 47
Clinical Trial Overview of National Cancer Institute 47
Memorial Sloan Kettering Cancer Center 51
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 51
European Organization for Research and Treatment of Cancer 52
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 52
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
Columbia University 54
Clinical Trial Overview of Columbia University 54
Istituto Clinico Humanitas 55
Clinical Trial Overview of Istituto Clinico Humanitas 55
Fox Chase Cancer Center 56
Clinical Trial Overview of Fox Chase Cancer Center 56
Stanford University 57
Clinical Trial Overview of Stanford University 57
University Health Network 58
Clinical Trial Overview of University Health Network 58
Five Key Clinical Profiles 59
Appendix 146
Abbreviations 146
Definitions 146
Research Methodology 147
Secondary Research 147
About GlobalData 148
Contact Us 148
Disclaimer 148
Source 149